Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy
Zechen Wang(Guangdong University of Petrochemical Technology), Karen S. Anderson(Arizona State University)
Cited by 15
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Strategy to Lengthen the On-Time of Photochromic Rhodamine Spirolactam for Super-resolution Photoactivated Localization Microscopy
|Journal of the American Chemical Society|2019|137
Characterization of Novel Reverse Transcriptase and Other RNA-associated Catalytic Activities by Human DNA Polymerase γ
|Journal of Biological Chemistry|2003|45
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies
|npj Precision Oncology|2022|17